Opportunity
NIH Reporter #5P30CA071789-24
Community Outreach and Engagement Grant for University of Hawaii Cancer Center
Posted
October 04, 2023
Respond By
September 22, 2025
Identifier
5P30CA071789-24
NAICS
541715, 541720, 923120
This opportunity is issued by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), for the Community Outreach and Engagement (COE) program at the University of Hawaii Cancer Center in Honolulu, HI. - Government Buyer: - National Cancer Institute (NCI), National Institutes of Health (NIH) - University of Hawaii Cancer Center, Honolulu, HI - Products/Services Requested: - Community-based research and outreach services - Health education and cancer prevention initiatives - Support for clinical trial participation - Culturally tailored interventions for Pacific Islander populations, including Native Hawaiians and residents of US-Affiliated Pacific Islands - OEMs and Vendors: - No specific OEMs or commercial vendors are mentioned; this is a grant opportunity for service delivery - Unique or Notable Requirements: - Emphasis on culturally appropriate strategies - Focus on addressing cancer disparities among Pacific Islander communities - Expansion of clinical trial participation among diverse populations - Activities must be tailored to the needs of the local community - Estimated Funding: - $219,100 for a one-year budget period - Period of Performance: - One-year budget period, with potential for multi-year project duration
Description
This NIH grant opportunity, issued by the National Cancer Institute (NCI), supports the Community Outreach and Engagement (COE) component of the University of Hawaii Cancer Center. The program focuses on leading or facilitating activities addressing cancers of priority for catchment populations including the Hawaiian archipelago and US-Affiliated Pacific Islands. It emphasizes culturally appropriate interventions, especially for Native Hawaiians and Pacific Islanders, to reduce cancer burden and improve health outcomes. The grant supports community-based research, outreach efforts, and expanding clinical trial participation among diverse populations.